Get a glimpse into our company and investor data—powered by the PitchBook Platform
Developer of cancer therapeutic medicines. The company provides diagnostic and prognostic technologies for cancer treatment.
This information is reserved for PitchBook Platform users. To explore Omnimmune Holdings (merged with Roughneck)‘s full profile, request access.
1 Former Executive
© 2019 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.